COMP <GO>
LNTH vs MRK // ENTERPRISE SCALE & MARKET CAP
Lantheus Holdings Inc. (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: LNTH 3
— MRK 11
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MRK
LAST: $100.46 (+0.14%) • MKT CAP: $6.55B
market-cap
$6.55B
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
market-cap
$361.02B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LNTH VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LNTH | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 61.10% | 74.80% | -13.70 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.30% | 20.70% | -0.40 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.0x | 15.3x | +2.70 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 4.90% | 3.42% | +1.48 | LNTH | /fcf-yield <GO> |
| Operating Margin | 20.20% | 34.30% | -14.10 | MRK | /operating-margins <GO> |
| Net Profit Margin | 15.20% | 28.10% | -12.90 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 0.50% | 1.30% | -0.80 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.34 | 5.19 | +0.15 | LNTH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.60% | -0.10 | LNTH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.0 | 56.9 | -0.81 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 0.92 | -0.04 | MRK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.0x | 18.4x | +7.60 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $6.55B | $361.02B | -$354.47B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LNTH REV | MRK REV | LNTH GROSS % | MRK GROSS % | LNTH FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.54B | $65.01B | 61.1% | 74.8% | $320.8M | $12.36B |
| FY 2024 | $1.53B | $64.17B | 64.4% | 76.3% | $475.7M | $18.10B |
| FY 2023 | $1.30B | $60.12B | 44.0% | 44.0% | $246.9M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LNTH // BETA 0.88
MRK // BETA 0.92